Articles published by Sonnet BioTherapeutics, Inc.
Via AccessWire
Tickers
SONN
Via AccessWire
Tickers
SONN
Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update
May 10, 2022
Via AccessWire
Exposures
Product Safety
Tickers
SONN
Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors
March 16, 2022
Via AccessWire
Exposures
Product Safety
Tickers
SONN
Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
February 08, 2022
Via AccessWire
Exposures
Product Safety
Tickers
SONN
Via AccessWire
Tickers
SONN
Sonnet BioTherapeutics Announces Pricing of $30 Million Underwritten Public Offering
August 19, 2021
Via AccessWire
Topics
Regulatory Compliance
Tickers
SONN
Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update
August 16, 2021
Via AccessWire
Topics
Intellectual Property
Tickers
SONN
Via AccessWire
Tickers
SONN
Via AccessWire
Tickers
SONN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.